NeuraLieve Garners $3,900,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    240 N. Wolfe Rd. Sunnyvale, CA 94085
  • Company Description
    Neuralieve is a medical technology company that is pursuing a completely new approach to
    the treatment of migraine headache. Our core technology is based on the science of transcranial magnetic stimulation (TMS), a modality that has been used extensively in brain research. In studying TMS for the treatment of headache, we believe we are breaking new ground in non-drug, non-behavioral therapy for migraine. We think that TMS has the potential to become a highly effective option for patients who need relief beyond that provided by today’s widely used pharmacologic agents and to offer patients a safe, effective alternative to existing drug therapy.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy